19 C
United States of America
Thursday, May 26, 2022

COVID-19 in Peru: more than 26 million 678 thousand Peruvians have already been vaccinated

Lima, February 11, 2022Updated on 02/11/2022 07:28 am

The Ministry of Health (Minsa) reported that as of Friday, February 11, the number of people vaccinated against COVID-19 with at least one dose amounts to 26,678,311. Meanwhile, the total number of citizens vaccinated with two doses is 23,426,883, until 6:00 a.m.

So far, Peru has received more than 26 million vaccines from Sinopharm, more than 34 million from Pfizer, and more than 4 million from AstraZeneca. All of these are applied according to the programming by age groups established by the Government after prioritizing health personnel, older adults and members of the National Police, Armed Forces and Firefighters.

Both the Sinopharm, Pfizer and AstraZeneca vaccines must be given in two doses to vaccinate a person against COVID-19.

The vaccination process in Peru began on February 9, 2020, in the main health centers in Lima and Callao. A digital tool implemented by the Minsa allows access to information on the progress of the dose application. You just have to click HERE to check the number of people vaccinated with both doses or with only one.

New vaccination plan

The Government established that a new vaccination plan against COVID-19 will begin on April 16, 2020, with the aim of vaccinating older adults first.

To do this, the Executive implemented the Pongo el Hombro platform, so that people can find out the location, date and time they will be vaccinated against the coronavirus (COVID-19).

Currently, the population is being inoculated from 5 years and older in Lima, Callao and in the regions of the country.

Seniors who cannot travel to their vaccination centers have the option of calling Line 113, so that a brigade can come to their home and apply the doses.

According to the criteria of

Trust Project

Know more


They approve orientation to resume face-to-face classes in universities
Latest news
- Advertisement -
Related news


Please enter your comment!
Please enter your name here